An increase relative to revenue may suggest rising input costs or inefficiencies in procurement, while a decrease suggests better cost control.
Represents the costs incurred for medical supplies, pharmaceuticals, and other consumables necessary for daily operation...
Comparable to cost of goods sold or supply expenses in other healthcare or manufacturing peers.
other_supplies_expense| Segment | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q1 '25 |
|---|---|---|---|---|---|---|---|---|
| DCS | $72.25M | $72.25M | $71.25M | $71.25M | $71.25M | $71.25M | $69.40M | $70.40M |
| JBI | $51.25M | $51.25M | $57.00M | $57.00M | $57.00M | $57.00M | $57.70M | $62.20M |
| FMS | $13.25M | $13.25M | $11.25M | $11.25M | $11.25M | $11.25M | $10.90M | $10.10M |
| JBT | $6.50M | $6.50M | $7.75M | $7.75M | $7.75M | $7.75M | $7.20M | $6.80M |
| ICS | $1.75M | $1.75M | $2.00M | $2.00M | $2.00M | $2.00M | $1.60M | $1.50M |
| Total | — | — | — | — | — | — | — | — |
DCS, FMS, ICS, JBI, JBT were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.